Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
TA664: Liraglutide for managing overweight and obesity
A March 2025 study by researchers at the University of Pennsylvania found 85% people on GLP-1s scored worse on a Waterless Empirical Taste Test, which involved touching flavored plastic strips to their tongues, compared to people not on the drugs
Why a Phased Approach Works Best Starting both peptides simultaneously makes it difficult to determine which one is responsible for any side effects you may experience
Liraglutide (Victoza), exenatide (Byetta), and semaglutide (Ozempic) have all been demonstrated to be highly successful for weight loss
Antioxidant & anti-inflammatory activity Researched in cell and animal models for antioxidant and anti-inflammatory activity
It is highly genetic
US$ 26.04
US$ 21.04
US$ 27.45
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 29.07
